Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer
Status:
Not yet recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
Surgical resection of the primary tumour and treatment of the metastatic site in
oligometastatic stage IV metastatic gastric adenocarcinoma enhances survival and improves
quality of life with acceptable postoperative morbidity and mortality in a selected group of
operable patients with only one metastatic site that does not progress under chemotherapy.